You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

5-fu

Showing 1 - 25 of 123
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Shreveport, Louisiana
  • +3 more
Oct 3, 2023

Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,

Recruiting
  • Colorectal Cancer
  • +4 more
  • Fosifloxuridine Nafalbenamide
  • +4 more
  • Wichita, Kansas
  • +5 more
Jan 9, 2023

Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)

Terminated
Has Results
  • Colorectal Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 10, 2022

Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Madrid, Spain
    Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022

Colorectal Cancer Trial (cadonilimab, irinotecan, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 20, 2023

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, cisplatin, 5-FU)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • pembrolizumab
  • +3 more
  • (no location specified)
Jul 13, 2022

Gastric Adenocarcinoma Trial (Pembrolizumab, Cisplatin, 5-FU)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Pembrolizumab
  • +4 more
  • (no location specified)
Aug 18, 2022

Nasopharyngeal Carcinoma, TNF, Chemo-radiotherapy Trial (5-fu, Cisplatin, Radiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +2 more
  • 5-fu
  • +4 more
  • (no location specified)
Jun 22, 2022

Recurrent Head Neck Cancer, Metastatic Head Neck Cancer Trial (Pembrolizumab, Cisplatin, Carboplatin)

Active, not recruiting
Has Results
  • Recurrent Head and Neck Cancer
  • Metastatic Head and Neck Cancer
  • Pembrolizumab
  • +4 more
  • (no location specified)
Aug 18, 2022

Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Tokyo (Nivolumab, 5-FU, CDDP)

Recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • Nivolumab
  • +3 more
  • Tokyo, Japan
    National Cancer Center Hospital
Apr 5, 2022

Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas Trial in Saint Louis (5-FU, Leucovorin, Liposomal Irinotecan)

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • 5-FU
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 29, 2021

Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Esophageal Cancer
  • (no location specified)
Jul 6, 2023

Gastric Carcinoma Stage IV, Esophagogastric Junction Adenocarcinoma Stage IV Trial in Moscow (Irinotecan, Oxaliplatin, 5-FU)

Recruiting
  • Gastric Carcinoma Stage IV
  • Esophagogastric Junction Adenocarcinoma Stage IV
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 11, 2021

Sinonasal Carcinoma Trial (drug, procedure, other)

Not yet recruiting
  • Sinonasal Carcinoma
  • (no location specified)
Dec 9, 2021

Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • 5-fu
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023

Esophageal Squamous Cell Carcinoma, Locally Advanced Carcinoma Trial in Nanjing (Tislelizumab, 5-FU, cis Platinum)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Locally Advanced Carcinoma
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Jul 19, 2022

Colorectal Tumors, Tumor Metastasis, Colonic Tumors Trial in Seoul (Atezolizumab, Bevacizumab, Oxaliplatin)

Active, not recruiting
  • Colorectal Neoplasms
  • +3 more
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jul 6, 2022

Unresectable Adenocarcinoma of the Esophagus, Metastatic Adenocarcinoma of the Esophagus, Unresectable Adenocarcinoma of Gastric

Completed
Has Results
  • Unresectable Adenocarcinoma of the Esophagus
  • +3 more
  • Los Angeles, California
  • +1 more
Sep 3, 2021

Metastatic Colorectal Cancer Trial in Munich (Irinotecan, Folinic Acid, 5-FU)

Recruiting
  • Metastatic Colorectal Cancer
  • Munich, Germany
    Klinikum der Universitaet Muenchen - Campus Grosshadern
Dec 2, 2021

Advanced Malignant Tumors Trial in Shanghai (AK104, AK117, Capecitabine tablets)

Recruiting
  • Advanced Malignant Tumors
  • Shanghai, China
    Shanghai Renji Hospital
Aug 9, 2022

Head and Neck Tumors Trial in Taipei, Taoyuan (NC-6004, Cetuximab, 5-FU)

Terminated
  • Head and Neck Neoplasms
  • Taipei, Taiwan
  • +2 more
Apr 29, 2021

Metastatic Colorectal Cancer Trial in Munich (Bevacizumab, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Munich, Germany
    Klinikum der Universitaet Muenchen
Dec 2, 2021

Metastatic Colorectal Cancer Trial in Kashiwa, Chiba, Nagoya, Aichi (BBI608, 5-FU, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • Kashiwa, Chiba, Japan
  • +1 more
Apr 9, 2022

Urothelial Carcinoma of the Bladder Trial in Washington, Baltimore, Philadelphia (drug, radiation, procedure)

Active, not recruiting
  • Urothelial Carcinoma of the Bladder
  • Washington, District of Columbia
  • +3 more
Dec 2, 2022

Gastric Cancer, Esophageal Cancer, Stomach Cancer Trial in Saint Louis (CA-4948, 5-FU, Leucovorin)

Not yet recruiting
  • Gastric Cancer
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 27, 2022